
Shares of medical equipment maker Thermo Fisher TMO.N rise 1.2% to $574.94 premarket
Co beats Q4 profit and revenue estimates on improved demand for its products and services used in developing therapies
Posts Q4 adj. profit of $6.10 per share, beating estimates of $5.94, as per data compiled by LSEG
Reports Q4 rev of $11.40 billion, ahead of estimates of $11.28 billion
Co says will provide 2025 forecast on earnings call
Stock had fallen 2% in 2024